UNIVERSITY OF UTAH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-02-28
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.utah.edu
Effects of Body Mass Index on the Hyperemic Response to Regadenoson
Not Applicable
Completed
- Conditions
- Decreased Vascular FlowEndothelial DysfunctionObesity
- Interventions
- First Posted Date
- 2009-03-11
- Last Posted Date
- 2011-05-24
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 30
- Registration Number
- NCT00859833
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram
- First Posted Date
- 2009-02-25
- Last Posted Date
- 2017-05-12
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 13
- Registration Number
- NCT00851006
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids
- First Posted Date
- 2009-02-19
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- University of Utah
- Registration Number
- NCT00846625
- Locations
- 🇺🇸
John Moran Eye Center, Salt Lake City, Utah, United States
Early Versus Standard Postpartum Insertion of the Etonogestrel Contraceptive Implant
Phase 4
Completed
- Conditions
- Complications; ContraceptiveFemale Lactation
- Interventions
- First Posted Date
- 2009-02-19
- Last Posted Date
- 2016-04-18
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 69
- Registration Number
- NCT00847587
- Locations
- 🇺🇸
University of Utah Hospital, Salt Lake City, Utah, United States
Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma
- First Posted Date
- 2009-02-19
- Last Posted Date
- 2017-12-20
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 90
- Registration Number
- NCT00847522
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)
Completed
- Conditions
- Neurofibromatosis Type 1
- First Posted Date
- 2009-02-13
- Last Posted Date
- 2018-05-03
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 112
- Registration Number
- NCT00844129
- Locations
- 🇺🇸
University Health Care, 50 North Medical Drive, Salt Lake City, Utah, United States
Oral Uridine for Treatment of Bipolar Depression in Adolescents
- First Posted Date
- 2009-02-11
- Last Posted Date
- 2018-03-26
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 42
- Registration Number
- NCT00841269
- Locations
- 🇺🇸
University of Utah School of Medicine, Salt Lake City, Utah, United States
Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure
- First Posted Date
- 2009-02-02
- Last Posted Date
- 2016-07-04
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 15
- Registration Number
- NCT00833365
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Neuroendocrine Mechanisms of Growth and Body Composition in Preterm and Term Infants
Completed
- Conditions
- Premature Birth
- First Posted Date
- 2009-02-02
- Last Posted Date
- 2017-12-26
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 72
- Registration Number
- NCT00833222
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Electronic Pharmacotherapy Risk Management
Completed
- Conditions
- AsthmaMental HealthPain
- Interventions
- Behavioral: provider feedbackBehavioral: patient interventionBehavioral: Process-level
- First Posted Date
- 2009-01-26
- Last Posted Date
- 2010-03-23
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 174000
- Registration Number
- NCT00828490
- Locations
- 🇺🇸
Multi-clinic site, Salt Lake City, Utah, United States
© Copyright 2025. All Rights Reserved by MedPath